[Hemodynamic and therapeutic aspects of acute myocardial infarct. II. Pharmacological evaluations and guidelines for therapy].
D000208:Acute Disease; D004077:Digoxin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004232:Diuretics; D014665:Vasodilator Agents; D004077:Digoxin; D011433:Propranolol; D006821:Hyaluronoglucosaminidase; D008775:Methylprednisolone
Aspetti emodinamici e terapeutici dell'infarto miocardico acuto. Parte ii: valutazioni farmacologiche e impostazione terapeutica.